Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |